(Q57306209)

Tuomas Heikkinen

2

0 references

Anne Kallioniemi

Anne Kallioniemi

4

0 references

Heli Nevanlinna

Heli Nevanlinna

10

0 references

Johanna Schleutker

5

Johanna Schleutker

0 references

Carl Blomqvist

7

Carl Blomqvist

0 references

Deborah Thompson

3

Deborah Thompson

0 references

Ralf Bützow

9

Ralf Bützow

0 references

Kaija Holli

6

Kaija Holli

0 references

Kristiina Aittomäki

8

Global cancer statistics, 2002

Kristiina Aittomäki

0 references

publication date

25 May 2011

0 references

published in

Human Molecular Genetics

0 references

volume

20

0 references

issue

16

0 references

page(s)

3278-3288

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Models of genetic susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Increased risk for cancer in patients with the Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Cancer risks and mortality in heterozygous ATM mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Common variants at 19p13 are associated with susceptibility to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Susceptibility pathways in Fanconi's anemia and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Biallelic inactivation of BRCA2 in Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Mutation of the RAD51C gene in a Fanconi anemia-like disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Intercepting pelvic cancer in the distal fallopian tube: theories and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

RAD51C germline mutations in breast and ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Mutation screening of RAD51C in male breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Molecular genetics of the Finnish disease heritage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Genetics of population isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

A recurrent mutation in PALB2 in Finnish cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Penetrance analysis of the PALB2 c.1592delT founder mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR229